Status:
COMPLETED
Innovation in Pulmonary Rehabilitation
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Pulmonary Disease
Pulmonary Emphysema
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The purpose of this study was to compare the effect of exercise treatment combined with breathing retraining (a computerized feedback program), with exercise treatment combined with heliox (a helium a...
Detailed Description
Dynamic hyperinflation limits exercise tolerance in patients with chronic obstructive pulmonary disease (COPD). Recently, several innovative approaches have been developed to reduce the burden of dyna...
Eligibility Criteria
Inclusion
- 40 years of age
- FEV1 70%
- FEV1/FVC \<70%
- RV/TLC \> 120%
Exclusion
- Respiratory infection/exacerbation within last 4 weeks
- Exercise limiting heart disease
- Primary asthma
- Congestive heart failure New York Heart Association (NYHA) Class III-IV
- Exercise limiting peripheral arterial disease or arthritis
- Inability to walk on a treadmill
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT00123422
Start Date
October 1 2005
End Date
September 1 2009
Last Update
October 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Edward Hines, Jr. VA Hospital
Hines, Illinois, United States, 60141-5000